Century Therapeutics is closing its Seattle operations as part of a 25% reduction in headcount and a shift in its priorities. The Philadelphia-based biotech startup launched a Seattle innovation hub… Read More
When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of remissions in leukemia patients treated with their own immune cells,… Read More
Cell therapy company Century Therapeutics will receive a $100 million up front payment and $50 million in equity investment from Bristol Myers Squibb in a deal announced Monday. Under the… Read More